234 related articles for article (PubMed ID: 28457804)
21. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
[TBL] [Abstract][Full Text] [Related]
22. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
23. New antihistamines: a critical view.
Camelo-Nunes IC
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S173-80. PubMed ID: 17136293
[TBL] [Abstract][Full Text] [Related]
24. Assessment of antihistamines in the treatment of skin allergies.
Murota H; Katayama I
Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):428-37. PubMed ID: 21841471
[TBL] [Abstract][Full Text] [Related]
25. Antihistamines in dermatology.
Greaves MW
Skin Pharmacol Physiol; 2005; 18(5):220-9. PubMed ID: 16015020
[TBL] [Abstract][Full Text] [Related]
26. Effects of first- and second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice.
Kamei J; Hirano S; Miyata S; Saitoh A; Onodera K
J Pharmacol Sci; 2005 Feb; 97(2):266-72. PubMed ID: 15699576
[TBL] [Abstract][Full Text] [Related]
27. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
[TBL] [Abstract][Full Text] [Related]
28. Antihistamines: ABC for the pediatricians.
Parisi GF; Licari A; Papale M; Manti S; Salpietro C; Marseglia GL; Leonardi S
Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():34-36. PubMed ID: 32017222
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.
Chen C; Hanson E; Watson JW; Lee JS
Drug Metab Dispos; 2003 Mar; 31(3):312-8. PubMed ID: 12584158
[TBL] [Abstract][Full Text] [Related]
30. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines.
Chishty M; Reichel A; Siva J; Abbott NJ; Begley DJ
J Drug Target; 2001 Jun; 9(3):223-8. PubMed ID: 11697207
[TBL] [Abstract][Full Text] [Related]
31. Histamine and migraine revisited: mechanisms and possible drug targets.
Worm J; Falkenberg K; Olesen J
J Headache Pain; 2019 Mar; 20(1):30. PubMed ID: 30909864
[TBL] [Abstract][Full Text] [Related]
32. Why are non-sedating antihistamines non-sedating?
Timmerman H
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():13-8. PubMed ID: 10444207
[TBL] [Abstract][Full Text] [Related]
33. Low dosage promethazine and loratadine negatively affect neuromotor function.
Kavanagh JJ; Grant GD; Anoopkumar-Dukie S
Clin Neurophysiol; 2012 Apr; 123(4):780-6. PubMed ID: 21880544
[TBL] [Abstract][Full Text] [Related]
34. Comparative pharmacology of the H1 antihistamines.
del Cuvillo A; Mullol J; Bartra J; Dávila I; Jáuregui I; Montoro J; Sastre J; Valero AL
J Investig Allergol Clin Immunol; 2006; 16 Suppl 1():3-12. PubMed ID: 17357372
[No Abstract] [Full Text] [Related]
35. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
Kavosh ER; Khan DA
Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
[TBL] [Abstract][Full Text] [Related]
36. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
37. [Molecular imaging of histamine receptors in the human brain].
Tashiro M; Yanai K
Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
[TBL] [Abstract][Full Text] [Related]
38. Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data.
Kanamitsu K; Nozaki Y; Nagaya Y; Sugiyama Y; Kusuhara H
Drug Metab Pharmacokinet; 2017 Apr; 32(2):135-144. PubMed ID: 28190755
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of efficacy and sedative profiles of H(1) antihistamines by large-scale surveillance using the visual analogue scale (VAS).
Izumi N; Mizuguchi H; Umehara H; Ogino S; Fukui H
Allergol Int; 2008 Sep; 57(3):257-63. PubMed ID: 18566547
[TBL] [Abstract][Full Text] [Related]
40. US Prescription trends of antihistamines for atopic dermatitis, 2011-2016.
Garg S; Zhao J; Tegtmeyer K; Shah P; Lio PA
Pediatr Dermatol; 2021 Jan; 38(1):324-326. PubMed ID: 33247474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
